Phathom Pharmaceuticals, Inc.盘中异动大幅下跌5.32%报3.18美元

市场透视2025-05-02

北京时间2025年05月02日21时44分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现波动，股价大幅跳水5.32%。截至发稿，该股报3.18美元/股，成交量18.0885万股，换手率0.26%，振幅5.36%。最近的财报数据显示，该股实现营业收入55.25百万美元，净利润-3.34亿美元，每股收益-5.29美元，毛利47.28百万美元，市盈率-0.62倍。...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2532825842?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-02 21:44","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2532825842","market":"us","top_or_hot":-1,"title":"Phathom Pharmaceuticals, Inc.盘中异动 大幅下跌5.32%报3.18美元","media":"市场透视","content":"<div>\n<p>北京时间2025年05月02日21时44分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现波动，股价大幅跳水5.32%。截至发稿，该股报3.18美元/股，成交量18.0885万股，换手率0.26%，振幅5.36%。最近的财报数据显示，该股实现营业收入55.25百万美元，净利润-3.34亿美元，每股收益-5.29美元，毛利47.28百万美元，市盈率-0.62倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214438aa2c81e0&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Phathom Pharmaceuticals, Inc.盘中异动 大幅下跌5.32%报3.18美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPhathom Pharmaceuticals, Inc.盘中异动 大幅下跌5.32%报3.18美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-02 21:44 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214438aa2c81e0&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年05月02日21时44分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现波动，股价大幅跳水5.32%。截至发稿，该股报3.18美元/股，成交量18.0885万股，换手率0.26%，振幅5.36%。最近的财报数据显示，该股实现营业收入55.25百万美元，净利润-3.34亿美元，每股收益-5.29美元，毛利47.28百万美元，市盈率-0.62倍。...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214438aa2c81e0&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214438aa2c81e0&s=b","article_id":"2532825842","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502214438aa2c81e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2532825842","pubTimestamp":1746193478,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年05月02日21时44分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.32%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。该信息摘要如下：HC Wainwright & Co.：维持Phathom Pharmaceuticals评级，由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4007":"制药","PHAT":"Phathom Pharmaceuticals"},"translate_title":"Phathom Pharmaceuticals, Inc. fell 5.32% to $3.18 in intraday moves","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHAT":1},"content_text":"北京时间2025年05月02日21时44分，Phathom Pharmaceuticals, Inc.（PHAT.us）股票出现波动，股价大幅跳水5.32%。截至发稿，该股报3.18美元/股，成交量18.0885万股，换手率0.26%，振幅5.36%。最近的财报数据显示，该股实现营业收入55.25百万美元，净利润-3.34亿美元，每股收益-5.29美元，毛利47.28百万美元，市盈率-0.62倍。机构评级方面，在所有8家参与评级的机构中，88%的券商给予买入建议，12%的券商给予持有建议，无券商给予卖出建议。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.43%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 (To Pur Com)、Impact Biomedical, Inc.、Adaptive Biotechnologies Corporation涨幅较大，Pmgc Holdings Inc.、Impact Biomedical, Inc.、Adial Pharmaceuticals, Inc较为活跃，换手率分别为306.31%、71.98%、69.40%，振幅较大的相关个股有Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 (To Pur Com)、Pmgc Holdings Inc.、Adaptive Biotechnologies Corporation，振幅分别为67.34%、22.59%、21.71%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。 该公司专注于开发和商业化胃肠道疾病的新型疗法。 它的产品由vonoprazan（一种口服的小分子钾竞争性酸阻滞剂）组成，可阻断胃酸的分泌。 Vonoprazan具有快速， 有效和持久的抗分泌作用，并已证明在治疗胃食管反流疾病以及与抗生素联合治疗幽门螺杆菌感染方面具有临床效益。消息层面，截至21时44分，《HC Wainwright & Co.：维持Phathom Pharmaceuticals评级，由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。》资讯为影响Phathom Pharmaceuticals, Inc.的重要信息。该信息摘要如下：HC Wainwright & Co.：维持Phathom Pharmaceuticals(PHAT.US)评级，由买入调整至买入评级, 目标价由28.00美元调整至20.00美元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2532825842","isCrawlerRequest":true}

Phathom Pharmaceuticals, Inc.盘中异动 大幅下跌5.32%报3.18美元

精彩评论

Phathom Pharmaceuticals, Inc.盘中异动大幅下跌5.32%报3.18美元